Profil
Mary Pinder-Schenck currently works at Revolution Medicines, Inc., as Senior Vice President-Medical Affairs from 2024.
Dr. Pinder-Schenck also formerly worked at National Comprehensive Cancer Network, Inc., as Member and Kite Pharma, Inc., as Head-US Medical Affairs.
Dr. Pinder-Schenck received her undergraduate degree from Wellesley College and doctorate degree from Stanford University School of Medicine.
Postes actifs de Mary Pinder-Schenck
| Sociétés | Poste | Début |
|---|---|---|
| REVOLUTION MEDICINES, INC. | Directeur Technique/Scientifique/R&D | 01/07/2024 |
Anciens postes connus de Mary Pinder-Schenck
| Sociétés | Poste | Fin |
|---|---|---|
National Comprehensive Cancer Network, Inc.
National Comprehensive Cancer Network, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services to fight against cancer | Corporate Officer/Principal | - |
| KITE PHARMA INC | Corporate Officer/Principal | - |
Formation de Mary Pinder-Schenck
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Wellesley College
Wellesley College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Comprehensive Cancer Network, Inc.
National Comprehensive Cancer Network, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services to fight against cancer | Commercial Services |
Kite Pharma, Inc.
Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
Stanford University School of Medicine
Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Revolution Medicines, Inc.
Revolution Medicines, Inc. Pharmaceuticals: OtherHealth Technology Develops new therapies derived from natural products | Health Technology |
















